VISTAGEN THERAPEUTICS, INC. Convertible Notes Payable, Current
VISTAGEN THERAPEUTICS, INC. (VTGN) had Convertible Notes Payable, Current of $35.80 thousand as of 2016-12-31, per its 10-Q filed 2017-02-13.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Long-Term Debt and Lease Obligation, Current › Long-Term Debt, Current Maturities › Notes and Loans Payable, Current › Notes Payable, Current
us-gaap:ConvertibleNotesPayableCurrent · last filed 2017-02-13
- 2016-12-31: Convertible Notes Payable, Current $35.80K.
- 2016-06-30: Convertible Notes Payable, Current $105.90K.
- 2016-03-31: Convertible Notes Payable, Current $31.60K.
- 2015-03-31: Convertible Notes Payable, Current $4.16M.
| Period end | Convertible Notes Payable, Current |
|---|---|
| 2016-12-31 | $35.80K 10-Q · filed 2017-02-13 |
| 2016-06-30 | $105.90K 10-Q · filed 2016-08-12 |
| 2016-03-31 | $31.60K 10-Q · filed 2017-02-13 |
| 2015-03-31 | $4.16M 10-K · filed 2016-06-24 |
| 2014-12-31 | $2.04M 10-Q · filed 2015-02-17 |
| 2014-09-30 | $1.56M 10-Q · filed 2014-11-19 |
| 2014-06-30 | $1.35M 10-Q · filed 2014-08-12 |
| 2014-03-31 | $396.00K 10-K · filed 2015-06-29 |
| 2013-12-31 | $169.20K 10-Q · filed 2014-02-14 |
| 2013-03-31 | $396.00K 10-Q · filed 2014-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |